Total Payments
$349,162
2024 Payments
$65,625
Companies
38
Transactions
1,570
Medicare Patients
4,115
Medicare Billing
$380,258
Payment Breakdown by Category
Other$269,127 (77.1%)
Travel$32,076 (9.2%)
Food & Beverage$28,544 (8.2%)
Consulting$19,285 (5.5%)
Education$130.08 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $209,427 | 115 | 60.0% |
| Travel and Lodging | $32,076 | 96 | 9.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $31,200 | 17 | 8.9% |
| Food and Beverage | $28,544 | 1,317 | 8.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $28,500 | 12 | 8.2% |
| Consulting Fee | $19,285 | 10 | 5.5% |
| Education | $130.08 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $146,838 | 316 | $0 (2024) |
| Gilead Sciences, Inc. | $70,874 | 129 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $63,765 | 460 | $0 (2024) |
| PFIZER INC. | $19,316 | 62 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $15,312 | 52 | $0 (2022) |
| Valeant Pharmaceuticals North America LLC | $10,800 | 50 | $0 (2017) |
| Eli Lilly and Company | $5,758 | 7 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $4,848 | 14 | $0 (2024) |
| RedHill Biopharma Inc. | $3,164 | 38 | $0 (2024) |
| Ardelyx, Inc. | $1,455 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $65,625 | 206 | ABBVIE INC. ($24,426) |
| 2023 | $36,095 | 193 | ABBVIE INC. ($20,070) |
| 2022 | $42,377 | 185 | ABBVIE INC. ($28,027) |
| 2021 | $23,630 | 170 | Gilead Sciences, Inc. ($8,137) |
| 2020 | $19,312 | 156 | Gilead Sciences, Inc. ($6,871) |
| 2019 | $49,341 | 256 | AbbVie, Inc. ($24,093) |
| 2018 | $56,118 | 210 | AbbVie, Inc. ($19,371) |
| 2017 | $56,665 | 194 | Gilead Sciences Inc ($20,420) |
All Payment Transactions
1,570 individual payment records from CMS Open Payments — Page 1 of 63
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Eli Lilly and Company | OMVOH (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Eli Lilly and Company | OMVOH (Drug) | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Eli Lilly and Company | OMVOH (Drug) | Travel and Lodging | Cash or cash equivalent | $33.93 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Lilly USA, LLC | OMVOH (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $9.38 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Lilly USA, LLC | OMVOH (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $7.60 | General |
| Category: Immunology | ||||||
| 12/17/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $32.55 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: Gastroenterology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.47 | General |
| Category: GI | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: Immunology | ||||||
| 12/04/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $34.37 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 12/04/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: LIVER DISEASE | ||||||
| 12/04/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: LIVER DISEASE | ||||||
| 12/03/2024 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | Cash or cash equivalent | $18.46 | General |
| Category: Antibiotic | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.78 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,720.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $13.77 | General |
| Category: GI | ||||||
| 11/12/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $36.36 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $4.27 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,038 | 2,117 | $450,854 | $100,593 |
| 2022 | 16 | 1,056 | 1,897 | $378,883 | $92,569 |
| 2021 | 18 | 1,261 | 2,252 | $477,977 | $118,677 |
| 2020 | 13 | 760 | 964 | $231,080 | $68,420 |
Total Patients
4,115
Total Services
7,230
Medicare Billing
$380,258
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 119 | 119 | $15,415 | $6,354 | 41.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 35 | 35 | $26,195 | $5,777 | 22.1% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2022 | 45 | 213 | $32,589 | $4,992 | 15.3% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2022 | 51 | 132 | $20,196 | $4,021 | 19.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 44 | $4,620 | $3,366 | 72.8% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2022 | 61 | 276 | $42,228 | $3,033 | 7.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 77 | 82 | $3,074 | $1,737 | 56.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $2,250 | $1,637 | 72.8% |
| 88377 | Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | Office | 2022 | 12 | 18 | $6,480 | $1,004 | 15.5% |
| 45330 | Diagnostic exam of lower portion of large bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $3,300 | $553.23 | 16.8% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 103 | 103 | $66,365 | $18,907 | 28.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 212 | 375 | $28,282 | $14,041 | 49.6% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 42 | 42 | $35,341 | $10,153 | 28.7% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 94 | 98 | $53,077 | $10,136 | 19.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 79 | 279 | $54,126 | $9,503 | 17.6% |
| 91120 | Testing of tone and sensation of rectum and anus | Office | 2021 | 19 | 28 | $17,500 | $9,225 | 52.7% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 165 | 165 | $21,840 | $7,955 | 36.4% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 37 | 38 | $26,980 | $6,517 | 24.2% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2021 | 67 | 168 | $25,704 | $5,357 | 20.8% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2021 | 40 | 203 | $31,059 | $4,949 | 15.9% |
| 91122 | Study of anorectal pressure generated by muscles surrounding anus (sphincter) | Office | 2021 | 20 | 29 | $17,900 | $4,205 | 23.5% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 63 | 65 | $4,875 | $3,335 | 68.4% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 147 | 157 | $6,262 | $3,118 | 49.8% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2021 | 78 | 272 | $41,616 | $3,084 | 7.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 33 | $3,525 | $2,684 | 76.1% |
About Dr. Sam Moskowitz, MD
Dr. Sam Moskowitz, MD is a Gastroenterology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1851377394.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sam Moskowitz, MD has received a total of $349,162 in payments from pharmaceutical and medical device companies, with $65,625 received in 2024. These payments were reported across 1,570 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($209,427).
As a Medicare-enrolled provider, Moskowitz has provided services to 4,115 Medicare beneficiaries, totaling 7,230 services with total Medicare billing of $380,258. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Brooklyn, NY
- Active Since 12/16/2005
- Last Updated 06/10/2011
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1851377394
Products in Payments
- Epclusa (Drug) $46,140
- XIFAXAN (Drug) $42,970
- RINVOQ (Biological) $33,513
- Mavyret (Drug) $30,427
- SKYRIZI (Biological) $23,164
- MAVYRET (Drug) $20,462
- VELSIPITY (Drug) $18,545
- Viekira (Drug) $14,149
- PLENVU (Drug) $11,344
- Humira (Biological) $11,242
- TRULANCE (Drug) $10,806
- CLENPIQ (Drug) $9,319
- HUMIRA (Biological) $7,125
- RELISTOR (Drug) $6,373
- PREPOPIK (Drug) $5,974
- Vosevi (Drug) $5,292
- OMVOH (Drug) $4,887
- VOQUEZNA (Drug) $4,848
- Talicia (Drug) $3,038
- APRISO (Drug) $2,239
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Brooklyn
Jianjun Li, M.d, M.D
Gastroenterology — Payments: $307,830
Gastroenterology $307,830
Dr. Nison Badalov, M.d, M.D
Gastroenterology — Payments: $237,374
Gastroenterology $237,374
Smruti Mohanty, Md, Ms, MD, MS
Gastroenterology — Payments: $219,216
Gastroenterology $219,216
Dr. Jonathan Erber, Md, MD
Gastroenterology — Payments: $208,708
Gastroenterology $208,708
Dr. Rabin Rahmani, M.d, M.D
Gastroenterology — Payments: $204,380
Gastroenterology $204,380
Kadirawelpillai Iswara, Md, MD
Gastroenterology — Payments: $191,623
Gastroenterology $191,623